Treib J, Fernandez A, Haass A, Grauer M T, Holzer G, Woessner R
Department of Neurology, University of the Saarland, Homburg, Germany.
Neurology. 1998 Nov;51(5):1489-91. doi: 10.1212/wnl.51.5.1489.
The authors performed a clinical and serologic follow-up study after 4.2 +/- 1.2 years in 44 patients with clinical signs of neuroborreliosis and specific intrathecal antibody production. All patients had been treated with ceftriaxone 2 g/day for 10 days. Although neurologic deficits decreased significantly, more than half the patients had unspecific complaints resembling a chronic fatigue syndrome and showed persisting positive immunoglobulin M serum titers for Borrelia in the Western blot analysis.
